SequelSEC

OMEROS CORP OMER

Pharmaceutical Preparations · CIK 0001285819 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$28.53M
Fiscal year ended 2026-06-30
Operating income
$74.00K
Fiscal year ended 2026-06-30
Free cash flow
$4.10M
Fiscal year ended 2026-06-30

OMEROS CORP (OMER) reported revenue of $28.53M and net income of $13.23M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from OMEROS CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

OMEROS CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-06-302025-03-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Revenue$28.53M$9.89M$0$0$30.00M$28.82M$21.06M$10.63M$26.11M$13.53M
Cost of revenue$798.00K$587.00K$0$0$333.00K$342.00K$263.00K$87.00K$401.00K$147.00K
Gross profit$27.73M$9.31M$0$0$29.67M$28.48M$20.80M$10.54M$25.71M$13.38M
Operating income$74.00K-$17.42M-$32.35M-$34.97M-$39.83M-$45.61M-$45.29M-$33.82M-$25.43M-$27.68M
Net income$13.23M$56.06M-$25.42M-$33.46M-$22.70M-$28.59M-$35.09M-$37.27M-$38.46M-$33.29M
Research & development$13.80M$13.36M$22.01M$23.85M$25.82M$30.13M$32.50M$23.25M$31.32M$24.13M
Weighted-average diluted sharesshares 89.63Mshares 90.12Mshares 58.59Mshares 58.06Mshares 62.51Mshares 62.37Mshares 61.93MUnavailableshares 58.23Mshares 54.51M
Pretax income$6.67M$51.31M-$25.89M-$37.56M-$22.70MUnavailableUnavailable-$87.75M-$46.32MUnavailable
Income tax expense$29.00K$57.00K$0$0UnavailableUnavailableUnavailable-$15.40M-$7.85MUnavailable
Diluted EPS$0.15$0.62$-0.43$-0.58$-0.36$-0.46$-0.57Unavailable$-0.66$-0.61
Selling, general & administrative$13.86M$13.37M$10.34M$11.12MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailableUnavailableUnavailable$14.01M$15.48M$12.79M-$5.49M$19.82M$16.93M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

OMEROS CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-06-302025-03-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Cash & equivalents$1.99M$1.91M$1.90M$4.26M$7.42M$12.70M$9.03M$10.50M$21.08M$1.96M
Total assets$286.83M$286.17M$200.57M$235.16M$123.43M$145.39M$161.44M$181.04M$227.08M$70.69M
Current assets$185.24M$180.36M$69.65M$96.18M$91.35M$112.40M$132.48M$151.28M$195.98M$38.93M
Total liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current liabilities$94.96M$59.44M$85.50M$83.22M$42.82M$47.70M$43.43M$36.74M$47.72M$38.05M
Total equity incl. NCI-$51.35M-$63.33M-$228.68M-$213.55M-$262.70M-$246.30M-$221.96M-$120.75M-$87.33M-$161.27M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$842.00K$183.00KUnavailableUnavailable$712.00K$978.00K$1.19M$1.36M$1.54M$1.89M
Accounts receivable$11.71M$6.75M$6.28M$7.08M$33.90M$31.84M$24.83M$3.84M$37.38M$15.78M
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailable$154.94M$164.94M$313.02M$312.58M$312.16M$236.29M$232.81MUnavailable
Accounts payable$6.34M$5.37M$8.84M$4.41M$10.03M$9.50M$11.50M$4.20M$7.02M$8.51M

Cash flow

OMEROS CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-06-302025-03-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Operating cash flow$4.15M-$14.51M-$21.94M-$35.84M-$23.66M-$27.59M-$40.25M-$18.41M-$34.94M-$37.60M
Capital expenditures$45.00K$0$13.00K$41.00K$103.00K$88.00K$12.00K$0$73.00K$144.00K
Investing cash flow$3.40M$28.73M$21.30M$38.54M$17.90M$30.41M$32.98M$8.00M-$118.40M$32.59M
Financing cash flow-$7.47M-$21.98M-$1.72M-$1.84M$478.00K$855.00K$5.80M-$163.00K$172.45M-$151.00K
Net change in cash$82.00K-$7.75M-$2.36M$861.00K-$5.29M$3.67M-$1.47M-$10.57M$19.11M-$5.15M
Stock-based compensation$1.62M$1.89M$2.06M$2.45M$5.69M$3.12M$3.27M$3.80M$3.82M$3.82M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$5.73M$4.15M$0$0UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$193.00K$239.00K$200.00K$289.00K$300.00K$400.00K$390.00K$398.00K$400.00K$400.00K

Derived

OMEROS CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-06-302025-03-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Free cash flow$4.10M-$14.51M-$21.95M-$35.88M-$23.76M-$27.68M-$40.27M-$18.41M-$35.01M-$37.74M
Gross margin97.2%94.1%UnavailableUnavailable98.9%98.8%98.8%99.2%98.5%98.9%
Operating margin0.3%-176.1%UnavailableUnavailableUnavailableUnavailableUnavailable-318.1%-97.4%-204.6%
FCF margin14.4%-146.6%UnavailableUnavailable-79.2%-96.0%-191.2%-173.1%-134.1%-278.9%
SBC / revenue5.7%19.1%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable14.6%28.2%
Current ratio1.95x3.03x0.81x1.16x2.13x2.36x3.05x4.12x4.11x1.02x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable14.9%113.0%-10.5%-68.2%-12.5%-49.4%
Net margin46.4%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable-350.6%-147.3%Unavailable
R&D / revenue48.4%135.0%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable119.9%178.4%
CapEx / revenue0.2%0.0%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable0.3%1.1%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate0.4%0.1%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OMER in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2019-09-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2019-06-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2019-03-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.